Everything below concerns Anti-doping testing. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-08-18. Where a claim depends on a specific study, the study is described rather than over-claimed.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ (NR1C2) | Nuclear receptor involved in lipid metabolism |
| Preclinical effect | Increased fatty acid oxidation | Observed in rodent studies |
| Key safety signal | Tumors in rodents after long-term exposure | Contributed to halted clinical development |
| Human trial status | No approved product; development stopped | Limited short-term metabolic data |
| Sport regulatory status | Prohibited at all times | WADA hormone and metabolic modulators class |
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
== See also == All pages with titles containing Link Linc (disambiguation) Lincs (disambiguation) Linker (disambiguation) Linq (disambiguation) Linx (disambiguation) Lynx (disambiguation) Microsoft Lync Linkt, road tolling brand in Australia
== Career and research == Ly is a full professor in the Department of Chemistry at Carnegie Mellon University, where he leads a multidisciplinary research group focused on synthetic biomolecules, DNA and RNA recognition, and molecular engineering. His laboratory has published on electron transport mechanisms in double-stranded DNA and the development of conformationally preorganized peptide nucleic acids (PNAs). This includes designing molecules capable of recognizing double-helical DNA or RNA through Watson-Crick base pairing. He also developed bifacial (Janus) nucleic acid recognition elements designed to bind to sequences of double-stranded DNA and target secondary or tertiary structures of RNA. In the biotechnology sector, Ly has co-founded startups based on his research, including Xpeutics, Vera Therapeutics (formerly PNA Innovations), and NeuBase Therapeutics (formerly ChiraGen).
== Application == Due to the hemolytic toxicity of Guanacastepene A, it is not currently used directly in human clinical medicine. Its main potential, however, lies in its function as a "resistance breaker" against antibiotic-resistant pathogens, as various experiments have demonstrated its efficacy against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE). Furthermore, a more specific area of application arises in antifungal research, as newly isolated members of the guanacastane family, such as guanacastepene V, isolated from the marine fungus Coprinellus xanthothrix discovered on the surface of a barnacle off the coast of Japan (Kashima City), exhibit a selective effect against the yeast Candida auris. This species is considered an emerging multidrug-resistant yeast. Although guanacastepene V inhibits the growth of Candida auris with an MIC of 6.25 µg/ml, it also exhibits high selectivity, as it has virtually no effect on Candida albicans at an MIC of 100 µg/ml. Therefore, opportunities may arise to further develop other members of the guanacastane family to combat Candida albicans outbreaks in hospitals. Guanacastepene A also serves as a challenging target molecule for total chemical synthesis, making it useful for developing and testing novel synthetic methods; examples include the controlled fragmentation of cyclobutane rings or innovative variants of the Robinson annulation reaction for constructing complex seven-membered ring systems.
All polyamides are made by the formation of an amide function to link two molecules of monomer together. The monomers can be amides themselves (usually in the form of a cyclic lactam such as caprolactam), α,ω-amino acids or a stoichiometric mixture of a diamine and a diacid. Both these kinds of precursors give a homopolymer. Polyamides are easily copolymerized, and thus many mixtures of monomers are possible which can in turn lead to many copolymers. Additionally many nylon polymers are miscible with one another allowing the creation of blends.
By taking command in person, Buller had allowed the overall direction of the war to drift. Because of concerns about his performance and negative reports from the field, he was replaced as Commander in Chief by Lord Roberts. Roberts assembled a new team for headquarters staff from far and wide: Lord Kitchener (Chief of Staff) from the Sudan; Frederick Russell Burnham (Chief of Scouts), the American scout, from the Klondike; George Henderson from the Staff College; Neville Bowles Chamberlain from Afghanistan; and William Nicholson (Military Secretary) from Calcutta. Like Buller, Roberts first intended to attack directly along the Cape Town–Pretoria railway but, again like Buller, was forced to relieve the beleaguered garrisons. Leaving Buller in command in Natal, Roberts massed his main force near the Orange River and along the Western Railway behind Methuen's force at the Modder River and prepared to make a wide outflanking move to relieve Kimberley. Except in Natal, the war had stagnated. Other than a single attempt to storm Ladysmith, the Boers made no attempt to capture the besieged towns. In the Cape Midlands, the Boers did not exploit the British defeat at Stormberg and were prevented from capturing the railway junction at Colesberg. In the dry summer, the grazing on the veld became parched, weakening the Boers' horses and draught oxen, and many Boer families joined their menfolk in the siege lines and laagers (encampments), fatally encumbering Cronjé's army.
Sources: en.wikipedia.org
==== Genetically modified organisms (GMOs) ==== Golden rice was a GMO created in 2005 through heterologous expression as a humanitarian effort to address the effects of Vitamin A deficiency. Oryza sativa rice was transfected with a gene to produce β-carotene, a Vitamin A precursor that has a yellow-orange color.
Short-acting psychedelics like DMT and 5-MeO-DMT show rapid and sustained antidepressant effects in treatment-resistant depression, potentially offering a more scalable alternative to psilocybin, though larger controlled trials are needed to confirm efficacy. A recent Phase 1/2 clinical trial evaluated the safety, tolerability, pharmacokinetics, and antidepressant effects of SPL026, an intravenous formulation of DMT fumarate, in both healthy volunteers and patients with moderate-to-severe major depressive disorder, using randomized, placebo-controlled and open-label dosing protocols. It found that inhaled 5-MeO-DMT (GH001) was well tolerated and produced rapid antidepressant effects in treatment-resistant depression, with individualized dosing showing the highest remission rates. A Phase 1 open-label study assessed the safety, tolerability, pharmacokinetics, and preliminary efficacy of intravenous SPL026 alone or combined with SSRIs in patients with major depressive disorder whose symptoms were not fully relieved by SSRIs. In a Phase 2a open-label trial, inhaled DMT produced rapid, well-tolerated, and sustained antidepressant effects in patients with treatment-resistant depression, showing high response and remission rates within 7 days and lasting up to 3 months. A single-day, open-label trial found that vaporized DMT produced rapid and sustained antidepressant effects in treatment-resistant depression, with up to 50% of participants maintaining remission one month post-dose.
== Mediated apoptosis == Once inside the target cell, granzyme B can cleave and activate initiator caspases 8 and 10, and executioner caspases 3 and 7 which trigger apoptosis. Caspase 7 is the most sensitive to granzyme B and caspases 3, 8, and 10 are only cleaved to intermediate fragments and need further cleavage for full activation. Granzyme B can also cleave BID leading to BAX/BAK oligomerisation and cytochrome c release from the mitochondria. Granzyme B can cleave ICAD leading to DNA fragmentation and the laddering pattern associated with apoptosis. Granzyme B has a potential of over 300 substrates and can cleave Mcl-1 in the outer mitochondrial membrane relieving its inhibition of Bim. Bim stimulates BAX/BAK oligomerisation, mitochondrial membrane permeability and apoptosis. Granzyme B can also cleave HAX1 (Hs-1 associated protein X-1) to facilitate mitochondria polarisation. Granzyme B can also generate a cytotoxic level of mitochondrial reactive oxygen species (ROS) to mediate cell death. The caspase independent pathways of cell death are thought to have arisen to overcome viruses that can inhibit caspases and prevent apoptosis.
== Commercial situation == As of 2017, Cytiva holds patents around three-column periodic counter-current chromatography: this technology is used in their Äkta PCC instrument. Likewise, ChromaCon holds patents for an optimized two-column version (CaptureSMB). CaptureSMB is used in ChromaCon's Contichrom CUBE and under license in YMC's Ecoprime Twin systems. Additional manufacturers of systems capable of periodic counter-current chromatography include Novasep and Pall.
=== Other toxicants === Carbon disulfide is a risk factor and has been identified in industrial worker case studies and has induced parkinsonism in mice. It is mainly used in the manufacture of viscose rayon and rubber. Carbon disulfide has been mixed with carbon tetrachloride for use in the fumigation of grain.
Sources: en.wikipedia.org
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.
Small short-term human trials examined metabolic markers such as lipids and glucose. The trials did not continue after rodent cancer findings, so long-term human safety is unknown.
Controlled human trials have not established a performance benefit. Anecdotal reports exist, but they are not reliable evidence.
Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.